Forecast to Publish a Notice of Funding Opportunity for Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Cancer Institute, in collaboration with the National Human Genome Research Institute and the National Institute of Biomedical Imaging and Bioengineering, plans to issue a Notice of Funding Opportunity aimed at supporting early-career academic scientists who are interested in transitioning to entrepreneurship. This initiative focuses on facilitating the transfer of technology from academic research laboratories to small businesses, which are critical channels for technological innovation in the United States. Recognizing the dual challenges of assembling the right entrepreneurial team and securing funding for early-stage technology development, the funding opportunity will provide support in both entrepreneurial mentoring and product development to enhance the transition process. The funding opportunity will utilize the R41/R42 activity codes and is not currently open for applications. The notice is being announced in advance to give potential applicants ample time to build collaborations and prepare strong proposals. The solicitation is expected to be published in Summer 2025, with applications due in Fall 2025. This effort reflects the NIH’s ongoing commitment to fostering the commercialization of academic discoveries through its SBIR and STTR programs, ultimately aiming to accelerate the delivery of innovative products that benefit public health.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Cancer Institute (NCI), with National Human Genome Research Institute (NHGRI) and National Institute of Biomedical Imaging and Bioengineering (NIBIB), intends to publish a Notice of Funding Opportunity (NOFO) to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR and STTR programs. As technologies transition from academic discovery to small businesses, two common challenges arise, identifying the right team with the right expertise to take the product into a small business, and funding for early-stage technology development. This NOFO seeks to address both challenges simultaneously by having two equally important goals: entrepreneurial mentoring support, and product development support.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the R41/R42 activity code. The NOFO is expected to be published in Summer 2025 with an anticipated application due date in Fall 2025.
